Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies.
Nawrot
U
U
Department of Microbiology, Wroclaw Medical University, Poland. nawrot@mbio.am.wroc.pl
Nowicka
J
J
Wlodarczyk
K
K
D000935:Antifungal Agents / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy / Q000209:etiology; D025141:Drug Resistance, Fungal; D015725:Fluconazole / Q000494:pharmacology*; D019337:Hematologic Neoplasms / Q000150:complications; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D011743:Pyrimidines / Q000494:pharmacology*; D014230:Triazoles / Q000494:pharmacology*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D015725:Fluconazole; D065819:Voriconazole; D007654:Ketoconazole